Molecular Fluorescence Endoscopy in Patients With Familial Adenomatous Polyposis, Using Bevacizumab-IRDye800CW

NCT02113202 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Adenomatous Polyposis Coli

Interventions

DRUG: Bevacizumab-IRDye800CW
DEVICE: Near infrared fluorescence endoscopy platform

Sponsor

University Medical Center Groningen